Outsourced Drug Development Solutions
-
Gain Human-Relevant Insights With Patient-Derived Assay-Ready Organoids
3/31/2025
3D organoids offer enhanced physiological relevance and are ready to use from cryopreserved vials. Discover how they can streamline your research with high-quality and comprehensive support.
-
Microbial CDMO Services
With over 30+ years’ of experience in microbial CDMO services, one of our core areas of expertise is the development of large-scale processes for recombinant protein expression in microbial hosts (E.coli, P.pastoris and S.cerevisiae).
-
Process Liquid Preparation Services
5/11/2022
We simplify pre-production workflows—for both upstream and downstream—by delivering fit-for-purpose process liquid and buffer preparation solutions that enable you to produce life-changing therapeutics and vaccines, faster.
-
CD34+ HSC LNP Kits
4/24/2025
Research Use Only (RUO) lipid nanoparticle (LNP) reagents to deliver RNA into hematopoietic stem cells (HSCs) for cell and gene therapy applications.
-
Bridging Molecules From Early Discovery To POC And Beyond
1/2/2024
Learn how this partnership improves flexibility for customers, offers dedicated project teams, and enables a bespoke service that is tailored to each development program.
-
FlexUP Technology Renewal Program
4/11/2022
Are you using obsolete or aging instruments simply because they continue to work? Running your laboratory with outdated technology brings about challenges beyond just headaches. Older technology may limit your performance, increase your costs, and open your lab up to risk. It may be time to investigate the real cost of using obsolete technology.
With the Waters FlexUP Technology Renewal Program, always work with the latest technology for optimum productivity and security.
-
Adare Pharma Solutions (APS) Orbis Overview
10/27/2020
Orbis provides innovative taste-making and controlled release solutions for oral and injectable pharmaceutical products.
-
Trusted End-To-End CDMO Partner For Your Journey
In an increasingly competitive environment, working with the right CDMO is vital for successful drug lifecycle management. We now serve more than half of the world’s leading biopharmaceutical companies, sharing their mission to expedite patient access to life-saving biologics.
-
Formulation Development
10/23/2024
Upperton offers formulation development services to accelerate First-in-Human studies and advance projects toward clinical trials.
-
Develop. De-risk. Deliver.
6/10/2021
Our solutions are tailored to guide and optimize your efforts, so you can be confident in your development strategy and execution plan. While we have a wide range of offerings ready and available, we are driven by one goal—to help you successfully realize yours.